Yousif Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Yousif Capital Management’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.02M	Buy	16,483 +251	+2%	+$26.2K	0.02%	683
2026 Q1	$1.71M	Sell	16,232 -49	-0.3%	-$4.34K	0.02%	750
2025 Q4	$1.36M	Sell	16,281 -2,145	-12%	-$176K	0.01%	920
2025 Q3	$1.22M	Sell	18,426 -4,978	-21%	-$283K	0.01%	992
2025 Q2	$1.29M	Buy	23,404 +1,067	+5%	+$51.2K	0.01%	986
2025 Q1	$1.08M	Sell	22,337 -581	-3%	-$24.3K	0.01%	1070
2024 Q4	$885K	Sell	22,918 -322	-1%	-$14K	0.01%	1214
2024 Q3	$1.05M	Buy	+23,240	New	+$939K	0.01%	1153

Other funds holding PTGX

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Yousif Capital Management's PTGX Position: Q2 2026 in Review

Yousif Capital Management increased its Protagonist Therapeutics (PTGX) stake by 1.5% in Q2 2026, buying an estimated $26.2K and bringing the position to 16,483 shares worth $2.02M. The position accounts for 0.02% of the portfolio, ranked #683.

Yousif Capital Management first reported a position in PTGX in Q3 2024 and has held it in 8 quarters since. 25 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

Yousif Capital Management held 16,483 shares of Protagonist Therapeutics worth $2.02M as of Q2 2026.
Yousif Capital Management bought 251 Protagonist Therapeutics shares in Q2 2026, an estimated $26.2K.
Protagonist Therapeutics made up 0.02% of Yousif Capital Management's portfolio in Q2 2026, its #683 holding.
Yousif Capital Management first reported a position in Protagonist Therapeutics in Q3 2024 and has held it in 8 quarters since.
25 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.